- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT07943429
Strategies to Improve RTS,S-4 Uptake and Integration With Other Child Health Services
Investigating Approaches to Increase the Uptake of Malaria Vaccine and Other Childhood Health Interventions in Western Kenya: a Feasibility Study
This study will identify and evaluate innovative approaches to leverage malaria vaccine visits as opportunities to enhance the delivery of other child health services in Rarieda sub-county, Siaya County, Kenya where RTS,S became part of their routine childhood immunization programs in 2019. Using a human-centred design approach, the implementation research will be conducted in two phases.
Phase 1 (Diagnose and Design) will consist of formative research to understand current practices, barriers, and facilitators for childhood health and malaria interventions using the WHO's behavioural and social drivers' framework for immunization. Having identified the barriers and facilitators to uptake, the investigators will prioritize drivers and develop innovations for implementation in collaboration with communities, healthcare workers and managers.
Phase 2 (Implement and Evaluate) will focus on implementing and evaluating the innovations developed in Phase 1. Using the RE-AIM (Reach, Effectiveness, Adoption, Implementation, and Maintenance) Framework, the study will assess the extent to which the interventions reach the target population, effectiveness of leveraging the malaria vaccine to increase uptake of other child health interventions, the extent of adoption by key stakeholders, and the fidelity and quality of implementation. The investigators will also explore cost and long-term sustainability.
The study will employ a mixed-methods approach, leveraging quantitative and qualitative data from health facility records, surveys, interviews, and observations.
The investigators will generate evidence on leveraging malaria vaccine visits and activities through: (i) innovative implementation strategies designed to maximize immunizations, child health interventions, and malaria prevention uptake; (ii) community engagement as an approach to optimize vaccine uptake and coverage; (iii) detailed qualitative data on the acceptability, perceptions, and barriers to uptake of vaccines and child health interventions; (iv) approaches to ensure access for zero-dose, under-vaccinated and underserved populations.
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
- Conductual: Provide ITNs at RTS,S-4 visit
- Conductual: Community Health Promoters identify and refer under-vaccinated children to health facilities
- Conductual: Enhanced defaulter tracing with use of mobile technology
- Conductual: Strengthening immunization systems, health services, and interdepartmental collaboration
Tipo de estudio
Inscripción (Actual)
Fase
- No aplica
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
-
Siaya, Kenia
- Ong'ielo Health Centre
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
-
Primary caregivers of children eligible for malaria vaccination:
- Inclusion criteria: Primary caregivers (age 18 years or older) of children who are eligible for or have received at least one dose of malaria vaccine
- Exclusion criteria: Caregivers who are not the primary decision-makers for the child's healthcare or who have resided in the study area for less than 3 months
-
Healthcare workers involved in immunization services:
- Inclusion criteria: Clinical officers, nurses, or other healthcare staff directly involved in providing immunization services at the selected health facilities for at least 3 months
- Exclusion criteria: Healthcare workers not involved in immunization service delivery or who have worked at the facility for less than 3 months
-
Community health promoters (CHPs):
- Inclusion criteria: CHPs working in the catchment areas of selected health facilities for at least 6 months
- Exclusion criteria: CHPs who have not been active in the past 3 months
-
Community members and leaders:
- Inclusion criteria: community members and leaders willing to share their views on malaria vaccine barriers and facilitators, and approaches to improve uptake.
- Exclusion criteria: Community members not willing to participate in the study
-
Health facility managers and sub-county/county/national health officials:
- Inclusion criteria: Health facility in-charges, sub-county or county EPI coordinators, and other relevant health officials overseeing immunization services across MoH hierarchy
- Exclusion criteria: Officials who have been in their current position for less than 3 months
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Prevención
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Ninguno (etiqueta abierta)
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: ITN - Provision of ITNs at RTS,S-4 visit
Leverage malaria vaccine to improve ITN access and use by providing ITNs at the 4th malaria dose visit, as well as vitamin A, deworming, MR2 and other missing vaccines |
- At RTS,S-4 visit, health workers (HW) screen children for missing vaccinations and health services - HW provide catch-up vaccinations and services |
|
Experimental: CHP - CHP identify and refer under-vaccinated children to health facility
Using malaria vaccine as an entry point, CHPs systematically identified under-vaccinated children during routine household visits and referred them to health facilities (HF), integrating immunization tracking into routine community activities. |
|
|
Experimental: SMS - Enhanced defaulter tracing with use of mobile technology
Facility-community linkages were strengthened through CHP engagement and mobile phone-based reminders, including SMS notifications and defaulter tracing |
|
|
Experimental: SS - Strengthening immunization systems, health services, and interdepartmental collaboration
Multi-component intervention: 1) strengthening immunizations and health services through interdepartmental collaboration; 2) improving vaccine visit awareness, preparedness, and defaulter tracing; and 3) targeted monthly community outreaches, with CHPs mobilizing caregivers of children due or overdue for vaccination. |
Conductual: Strengthening immunization systems, health services, and interdepartmental collaboration
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Reach
Periodo de tiempo: Three months
|
Vaccine coverage (%) in target populations and characteristics of vaccinated populations reached through study interventions |
Three months
|
|
Effectiveness
Periodo de tiempo: Three months
|
Percentage increase in primary (dose 1-3) and booster (4th) doses post-interventions in age-eligible children |
Three months
|
|
Adoption
Periodo de tiempo: Three months
|
Proportion of RTS,S vaccines provided concurrently with other vaccines/services. |
Three months
|
|
Implementation
Periodo de tiempo: Three months
|
Perceived feasibility of interventions by health workers, caregivers, and community. A semi-structured interview guide will be used to assess implementation experiences. |
Three months
|
|
Maintenance
Periodo de tiempo: Three months
|
Drivers of maintenance of interventions. A semi-structured interview guide will be used to elicit what it would take to continue implementing interventions beyond the study period. |
Three months
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Investigador principal: Simon Kariuki, PhD, Kenya Medical Research Institute
- Investigador principal: Nelli Westercamp, PhD, Centres for Disease Control and Prevention
Publicaciones y enlaces útiles
Publicaciones Generales
- UNICEF Office of Innovation. Human-Centered Design. UNICEF.
- Malaria vaccines (RTS,S and R21). WHO. https://www.who.int/news-room/questions-and-answers/item/q-a-on-rts-s-malaria-vaccine.
- Kenya Medical Research Institute, Centers for Disease Control and Prevention. Kenya MVPE Feasibility Evaluation: Results of the baseline household survey. Published November 2020.
- President's Malaria Initiative. Kenya PMI Fact Sheet In-Country FY 2023. PMI.gov. https://www.pmi.gov/wp-content/uploads/2023/04/Kenya_PMI-Fact-Sheet-InCountry_FY2023_CP_checked.pdf
- Boselli G, Yajima A, Aratchige PE, Feldon KE, Xeuatvongsa A, Phounphenghak K, Sihakhang K, Chitsavang C, Phengkeo S, Gabrielli AF, Politi C, Montresor A. Integration of deworming into an existing immunisation and vitamin A supplementation campaign is a highly effective approach to maximise health benefits with minimal cost in Lao PDR. Int Health. 2011 Dec;3(4):240-5. doi: 10.1016/j.inhe.2011.08.002.
- Wallace A, Dietz V, Cairns KL. Integration of immunization services with other health interventions in the developing world: what works and why? Systematic literature review. Trop Med Int Health. 2009 Jan;14(1):11-9. doi: 10.1111/j.1365-3156.2008.02196.x. Epub 2008 Nov 12.
- Ching P, Birmingham M, Goodman T, Sutter R, Loevinsohn B. Childhood mortality impact and costs of integrating vitamin A supplementation into immunization campaigns. Am J Public Health. 2000 Oct;90(10):1526-9. doi: 10.2105/ajph.90.10.1526.
- Oresanya O, Phillips A, Okereke E, Ahmadu A, Ibinaiye T, Marasciulo M, Ward C, Adesoro O, Mohammed R, Nikau J, Isokpunwu CO, Inname MA, Counihan H, Baker K, Maxwell K, Smith H. Co-implementing vitamin A supplementation with seasonal malaria chemoprevention in Sokoto State, Nigeria: a feasibility and acceptability study. BMC Health Serv Res. 2022 Jul 5;22(1):871. doi: 10.1186/s12913-022-08264-z.
- National Malaria Control Programme. Towards Malaria-Free Kenya: Kenya Malaria Strategy 2019-2023. Nairobi, Kenya: Ministry of Health; 2019.
- Elnour Z, Grethe H, Siddig K, Munga S. Malaria control and elimination in Kenya: economy-wide benefits and regional disparities. Malar J. 2023 Apr 7;22(1):117. doi: 10.1186/s12936-023-04505-6.
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Actual)
Finalización del estudio (Actual)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- KEMRI/SERU/CGHR/537/5206
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Descripción del plan IPD
Only aggregated data is required for reports and manuscripts.
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .